Cytek Biosciences

$Cytek Biosciences(CTKB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001872873-25-000002  Size: 26 KB 网页链接

$Cytek Biosciences(CTKB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001991396-25-000002  Size: 20 KB 网页链接

$Cytek Biosciences(CTKB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001515140-25-000002  Size: 7 KB 网页链接

$Cytek Biosciences(CTKB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-26-011748  Act: 34  Size: 156 KB 网页链接

$Cytek Biosciences(CTKB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001873091-25-000002  Size: 25 KB 网页链接

$Cytek Biosciences(CTKB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001874041-25-000002  Size: 26 KB 网页链接

$Cytek Biosciences(CTKB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001337252-25-000004  Size: 7 KB 网页链接

$Cytek Biosciences(CTKB)$ Topline Capital Management, LLC 已提交13G表格，表明其增持了Cytek Biosciences, Inc.的普通股。截至2025年11月17日，Topline Capital Management实益持有6,780,847股，占该公司5.3%的股权。这较此前持仓量有显著增长，持股数量增加29.62%，持仓价值增长101.68%。申报...

$Cytek Biosciences(CTKB)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-284205  Act: 34  Size: 193 KB 网页链接

$Cytek Biosciences(CTKB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001878824-25-000002  Size: 14 KB 网页链接

$Cytek Biosciences(CTKB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001398344-25-020758  Act: 34  Size: 7 KB 网页链接